Universal-Beteiligungs- und Servicegesellschaft
NBIX icon

Universal-Beteiligungs- und Servicegesellschaft’s Neurocrine Biosciences NBIX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Buy
99,912
+29,586
+42% +$4.39M 0.03% 456
2026
Q1 		$9.27M Buy
70,326
+5,299
+8% +$703K 0.02% 632
2025
Q4 		$9.22M Buy
65,027
+7,183
+12% +$1.04M 0.02% 643
2025
Q3 		$8.12M Sell
57,844
-174
-0.3% -$23.6K 0.01% 667
2025
Q2 		$7.29M Sell
58,018
-8,652
-13% -$992K 0.01% 680
2025
Q1 		$7.37M Sell
66,670
-1,359
-2% -$172K 0.01% 665
2024
Q4 		$9.29M Buy
+68,029
New +$8.41M 0.02% 562

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's NBIX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Neurocrine Biosciences (NBIX) stake by 42% in Q2 2026, buying an estimated $4.39M and bringing the position to 99,912 shares worth $16.8M. The position accounts for 0.03% of the portfolio, ranked #456.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in NBIX in Q4 2024 and has held it in 7 quarters since. 526 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 99,912 shares of Neurocrine Biosciences worth $16.8M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 29,586 Neurocrine Biosciences shares in Q2 2026, an estimated $4.39M.
  • Neurocrine Biosciences made up 0.03% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #456 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Neurocrine Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 526 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.